We provide necessary pharmaceuticals

A Nordic Specialty Pharma company

Abcur AB (Nordic Division in Concordia International) is a Nordic pharmaceutical company focusing on the development, registration and marketing of pharmaceuticals where there are no approved alternatives. Our goal is to make the necessary medicines available in the Nordic countries. Priority therapies include dependence, anesthetic and intensive care and pain. On 21 October 2015 Abcur AB (formerly AMCo Norden) became part of the Canadian company Concordia, through their acquisition of AMCo.

Concordia International Corp. is an international specialty pharmaceutical company with a diversified portfolio of more than 200 patented and off-patent products, and sales in more than 90 countries. Concordia is listed on TSX and Nasdaq and has its headquarters in Oakville, Ontario, Canada.

READ MORE ABOUT ABCUR

COMMUNITY INVOLVEMENT

Abcur cares, read about our engagement in ethics, environment and how we support charity organisations.

RESEARCH AND DEVELOPMENT

Abcur is involved in development of substances and widening of indications. Read more about our philosophy.

CAREER AT ABCUR

Working at Abcur means that you want to take part in our organisation. Your work and your opinion are valued.

OBSERVERA